These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31761997)

  • 1. How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness.
    Kearns B; Stevens J; Ren S; Brennan A
    Pharmacoeconomics; 2020 Feb; 38(2):193-204. PubMed ID: 31761997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer.
    Gray J; Sullivan T; Latimer NR; Salter A; Sorich MJ; Ward RL; Karnon J
    Med Decis Making; 2021 Feb; 41(2):179-193. PubMed ID: 33349137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia.
    Cope S; Ayers D; Zhang J; Batt K; Jansen JP
    BMC Med Res Methodol; 2019 Sep; 19(1):182. PubMed ID: 31477025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England.
    Buyukkaramikli NC; Wigfield P; Hoang MT
    Eur J Health Econ; 2021 Feb; 22(1):51-73. PubMed ID: 32901420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma.
    Whittington MD; McQueen RB; Ollendorf DA; Kumar VM; Chapman RH; Tice JA; Pearson SD; Campbell JD
    JAMA Netw Open; 2019 Feb; 2(2):e190035. PubMed ID: 30794298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
    Clarke A; Pulikottil-Jacob R; Grove A; Freeman K; Mistry H; Tsertsvadze A; Connock M; Court R; Kandala NB; Costa M; Suri G; Metcalfe D; Crowther M; Morrow S; Johnson S; Sutcliffe P
    Health Technol Assess; 2015 Jan; 19(10):1-668, vii-viii. PubMed ID: 25634033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A Tutorial.
    Sweeting MJ; Rutherford MJ; Jackson D; Lee S; Latimer NR; Hettle R; Lambert PC
    Med Decis Making; 2023 Aug; 43(6):737-748. PubMed ID: 37448102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma.
    Bakker LJ; Thielen FW; Redekop WK; Groot CU; Blommestein HM
    BMC Med Res Methodol; 2023 May; 23(1):132. PubMed ID: 37248477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study.
    Beca JM; Chan KKW; Naimark DMJ; Pechlivanoglou P
    BMC Med Res Methodol; 2021 Dec; 21(1):282. PubMed ID: 34922454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapolating Parametric Survival Models in Health Technology Assessment: A Simulation Study.
    Gallacher D; Kimani P; Stallard N
    Med Decis Making; 2021 Jan; 41(1):37-50. PubMed ID: 33283635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Woods B; Schmitt L; Jankovic D; Kearns B; Scope A; Ren S; Srivastava T; Ku CC; Hamilton J; Rothery C; Bojke L; Sculpher M; Harnan S
    Health Technol Assess; 2024 Jun; 28(28):1-238. PubMed ID: 38938145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Gallacher D; Armoiry X; Auguste P; Court R; Mantopoulos T; Patterson J; De Santis M; Cresswell J; Mistry H
    Pharmacoeconomics; 2019 Jan; 37(1):19-27. PubMed ID: 30030817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SurvInt: a simple tool to obtain precise parametric survival extrapolations.
    Gallacher D
    BMC Med Inform Decis Mak; 2024 Mar; 24(1):76. PubMed ID: 38486175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of domiciliary non-invasive ventilation in patients with end-stage chronic obstructive pulmonary disease: a systematic review and economic evaluation.
    Dretzke J; Blissett D; Dave C; Mukherjee R; Price M; Bayliss S; Wu X; Jordan R; Jowett S; Turner AM; Moore D
    Health Technol Assess; 2015 Oct; 19(81):1-246. PubMed ID: 26470875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic and Flexible Survival Models for Extrapolation of Relative Survival: A Case Study and Simulation Study.
    Kearns B; Stevenson MD; Triantafyllopoulos K; Manca A
    Med Decis Making; 2022 Oct; 42(7):945-955. PubMed ID: 35769004
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.